Ambulatory Transradial Percutaneous Coronary Intervention

Original title: Ambulatory Transradial Percutaneous Coronary Intervention: A Safe, Effective, and Cost-Saving Strategy. Reference: Philippe Le Corvoisier et al. Catheterization and Cardiovascular Interventions 81:15–23 (2013).

The number of PCI procedures has increased and for many interventional cardiology centers PC interventions entail significant resource consumption. Reducing post procedure hospital stay could reduce costs and optimize hospitalization resources. 

The safety of post PCI discharge the same day of procedure should be established before incorporation to daily practice. The aim of this prospective multicenter study was to determine the safety, cost and acceptance of patients undergoing ambulatory transradial PCI. The study took place in 3 high volume centers in France; it assessed 370 consecutive patients with stable angina or silent ischemia for coronary catheterization followed by PCI and same day discharge. From 370 patients, 220 were selected for 4-6 hr observation and discharge. 

Inclusion criteria were:

•+18 years

•Stable angina or silent ischemia

Exclusion criteria: 

•Clinical criteria

ACS, Symptomatic cardiac insufficiency and/or <35% ejection fraction, Severe chronic kidney disease (creatinine clearance

•Social criteria

Doubts on patient acceptance, Place of residence farther than 1 hour from hospital, Inadequate home care.

•PCI related criteria

Approach other than radial, Use of Glycoprotein IIb/IIIa inhibitors, < 3 post interventional TIMI flow , > 1 mm branch occlusion, Persistent chest pain, Hemodynamic instability during procedure, Ventricular arrhythmia during procedure, Procedure completed after 2 pm.

From the 220 patients, 213 (96.8%) were discharged after a 4-6 hr observation period. 4 patients remained hospitalized (1.8%) for cardiovascular reasons and 3 patients (1.4%) for non cardiovascular reasons. At one month follow up, one patient presented a non fatal infarction at day 4 for stent thrombosis and 3 patients were readmitted for atypical chest pain, without ECG changes or troponin elevation. 87% of patients were satisfied with ambulatory management and 96% were open to repeat the experience.

Conclusion 

Ambulatory PCI in stable patients is safe, feasible and well accepted by patients. It’s a promising strategy to lower costs and optimize healthcare resources.

Editorial Comment:

As an observational study, it fails to identify prediction factors; however, the study provides evidence in support of ambulatory PCI as daily practice: it included a significant number of patients with multiple vessels, bifurcations and recanalizations, due to the fact that all PCI procedures were ad hoc, which has external value and easily proves feasibility. Perhaps we could start including the least complex procedures and gain experience to include all procedures, as the present study did.

SOLACI.ORG

More articles by this author

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...